Safety and Efficacy Study of TNX-102 SL in Participants With PTSD
Clinical trial NCT05372887 · WITHDRAWN
Trial details
- NCT number
- NCT05372887
- Sponsor
- Tonix Pharmaceuticals, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-14
- Primary completion
- 2022-11-08
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.